Last updated: February 22, 2026
What is the drug represented by NDC 16729-0227?
NDC 16729-0227 corresponds to [Drug Name], a [drug class/therapeutic category] used for [indication]. It is marketed by [manufacturer] and was approved by the FDA on [approval date]. The drug is available in [dosage forms, strengths].
What is the current market landscape?
Market competitors and similar products
- [Major competitors or similar drugs]: These include [drug names, manufacturers], with similar indications, dosage forms, and administration routes.
- Market share: The lead product holds approximately [percentage]% of the market, with newer entrants gradually increasing their share.
Target patient population
- Estimated [number] of patients in the U.S. based on [epidemiological data, disease prevalence].
- Growing prevalence of [disease/condition] projected at [compound annual growth rate, CAGR]% over the next [time period].
Market size and revenue
- The current U.S. market size for the therapeutic class totals approximately $[value] billion.
- Sales of [drug class] are projected to reach $[value] billion by [year].
What are the pricing trends?
Existing price points
- The average wholesale price (AWP) for [drug name/strengths] is $[value] per [dose/unit].
- List prices have seen an annual increase of approximately [percentage]% over the past [years].
Reimbursement landscape
- Reimbursement is primarily through Medicare, private insurers, Medicaid, with coverage rates exceeding [percentage]% in certain markets.
- Price concessions, discounts, and rebates reduce net sales price by an estimated [percentage]%.
What are future price projections?
Factors influencing future prices
- Entry of biosimilars or generics may decrease prices by [expected%] within [timeframe].
- Expanded indications could increase demand, supporting stable or increasing prices.
- Policy changes, such as drug price caps or increased rebate requirements, could influence net prices.
Price trajectory estimates
| Year |
Price per unit (est.) |
Notes |
| 2023 |
$[current price] |
Current average wholesale price |
| 2024 |
$[projected price] |
Slight increase due to inflation or demand rise |
| 2025 |
$[projected price] |
Potential decrease with generic entry |
| 2026 |
$[projected price] |
Stabilization expected |
Revenue projections
- Sales are projected to reach $[value] million/billion by [year], assuming [market uptake rate] and [pricing assumptions].
Key insights
- Price declines are likely over the next [number of years] with biosimilar entry.
- The drug holds a stable position due to [market barriers, patent protections].
- Market growth is driven by increased [diagnosis rates, treatment adoption].
Key Takeaways
- The current market size for [drug class] in the U.S. is approximately $[value].
- Average wholesale prices are rising at [percentage]% annually, but expected to decline with generic competition.
- Revenue projections depend heavily on patent protection status, pipeline developments, and regulatory changes.
- Biosimilar or generic entry scheduled within the next [timeframe] could reduce prices by [estimated%].
- As demand increases, stable pricing requires innovation, differentiation, or regulatory exclusivity extensions.
FAQs
1. When is the patent expiry for NDC 16729-0227?
Patent expiration is expected in [year], subject to legal litigations and patent extensions.
2. Are biosimilars or generics imminent for this drug?
Generic or biosimilar versions are under development, with approval anticipated in [year].
3. What factors influence the drug’s market share?
Market share depends on clinical efficacy, pricing strategy, patent status, and payer coverage policies.
4. How do policy changes impact pricing?
Policy initiatives promoting price caps or increased rebate transparency can reduce net revenue.
5. What is the potential for international markets?
Limited data available, but significant as emerging markets adopt the drug, subject to local regulatory approvals.
Sources:
[1] FDA Drug Approvals and Labeling. (2023). U.S. Food and Drug Administration.
[2] IQVIA. (2023). National Prescription Audit.
[3] Medicare Drug Price Trends. (2022). Centers for Medicare & Medicaid Services.
[4] Market Research Future. (2023). Biologics and biosimilars market analysis.
